======= XRCC1 ======= == Gene Information == * **Official Symbol**: XRCC1 * **Official Name**: X-ray repair cross complementing 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=7515|7515]] * **UniProt**: [[https://www.uniprot.org/uniprot/P18887|P18887]] * **Interactions**: [[https://thebiogrid.org/search.php?search=XRCC1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20XRCC1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/194360|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene is involved in the efficient repair of DNA single-strand breaks formed by exposure to ionizing radiation and alkylating agents. This protein interacts with DNA ligase III, polymerase beta and poly (ADP-ribose) polymerase to participate in the base excision repair pathway. It may play a role in DNA processing during meiogenesis and recombination in germ cells. A rare microsatellite polymorphism in this gene is associated with cancer in patients of varying radiosensitivity. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Involved in DNA single-strand break repair by mediating the assembly of DNA break repair protein complexes. Probably during DNA repair, negatively regulates ADP-ribose levels by modulating ADP-ribosyltransferase PARP1 activity. {ECO:0000269|PubMed:28002403}. |PTCB-BRCT| |BRCT| |XRCC1 N| |positive regulation of DNA ligase activity| |oxidized DNA binding| |regulation of DNA ligase activity| |positive regulation of single strand break repair| |negative regulation of protein ADP-ribosylation| |3 overhang single-stranded DNA endodeoxyribonuclease activity| |telomeric DNA-containing double minutes formation| |negative regulation of protection from non-homologous end joining at telomere| |regulation of protection from non-homologous end joining at telomere| |base-excision repair, DNA ligation| |regulation of single strand break repair| |replication-born double-strand break repair via sister chromatid exchange| |negative regulation of telomere maintenance in response to DNA damage| |regulation of telomere maintenance in response to DNA damage| |ERCC4-ERCC1 complex| |positive regulation of DNA ligation| |regulation of DNA ligation| |positive regulation of ligase activity| |single strand break repair| |voluntary musculoskeletal movement| |negative regulation of telomere capping| |DNA ligation involved in DNA repair| |regulation of ligase activity| |regulation of protein ADP-ribosylation| |telomere maintenance via recombination| |DNA ligation| |mitotic recombination| |response to hydroperoxide| |nucleotide-excision repair, DNA gap filling| |regulation of telomere capping| |negative regulation of telomere maintenance| |cerebellum morphogenesis| |base-excision repair| |hindbrain morphogenesis| |multicellular organismal movement| |musculoskeletal movement| |double-strand break repair via nonhomologous end joining| |non-recombinational repair| |positive regulation of DNA repair| |transcription-coupled nucleotide-excision repair| |negative regulation of response to DNA damage stimulus| |hippocampus development| |regulation of telomere maintenance| |double-strand break repair via homologous recombination| |telomere maintenance| |positive regulation of response to DNA damage stimulus| |recombinational repair| |telomere organization| |cerebellum development| |limbic system development| |nuclear chromosome, telomeric region| |nucleotide-excision repair| |metencephalon development| |negative regulation of DNA metabolic process| |regulation of DNA repair| |negative regulation of chromosome organization| |hindbrain development| |pallium development| |double-strand break repair| |positive regulation of DNA metabolic process| |regulation of response to DNA damage stimulus| |DNA recombination| |nuclear chromatin| |telencephalon development| |anatomical structure homeostasis| |response to hypoxia| |enzyme binding| |regulation of chromosome organization| |regulation of DNA metabolic process| |response to decreased oxygen levels| |negative regulation of organelle organization| |response to oxygen levels| |response to oxidative stress| |forebrain development| |DNA repair| |negative regulation of protein modification process| |negative regulation of cellular component organization| |regulation of cellular response to stress| |brain development| |DNA metabolic process| |cellular response to DNA damage stimulus| |head development| |nucleolus| |central nervous system development| |response to drug| |negative regulation of cellular protein metabolic process| |chromosome organization| |negative regulation of protein metabolic process| |response to abiotic stimulus| |regulation of organelle organization| |positive regulation of catalytic activity| |negative regulation of nucleobase-containing compound metabolic process| |regulation of response to stress| |response to oxygen-containing compound| |negative regulation of response to stimulus| |homeostatic process| |cellular response to stress| |positive regulation of molecular function| |regulation of protein modification process| |positive regulation of nucleobase-containing compound metabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp299|Talazoparib 0.006μM R06 exp299]]|-2.64| |[[:results:exp520|Rucaparib 6.5μM R08 exp520]]|-1.94| |[[:results:exp189|Temozolomide 200μM R04 exp189]]|-1.89| |[[:results:exp270|Campthothecin 0.001μM R06 exp270]]|-1.82| |[[:results:exp512|Olaparib 4μM R08 exp512]]|-1.8| |[[:results:exp12|Chloramphenicol 2μM R00 exp12]]|1.71| ^Gene^Correlation^ |[[:human genes:c:chtf8|CHTF8]]|0.454| Global Fraction of Cell Lines Where Essential: 7/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|1/28| |blood|0/28| |bone|1/26| |breast|2/33| |central nervous system|1/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1804 * **Expression level (log2 read counts)**: 4.96 {{:chemogenomics:nalm6 dist.png?nolink |}}